...but hey, do what you want...you will anyway.A week after appearing to project a more serious tone about the coronavirus, President Donald Trump is back to pushing unproven claims that an anti-malaria drug is an effective treatment and challenging the credibility of the nation's leading infectious disease expert.
[...]
[A]fter returning from a trip to North Carolina in which he promoted efforts to develop a COVID-19 vaccine, Trump retweeted a series of tweets advocating for hydroxychloroquine.
[...]
Dr Anthony Fauci pushed back Tuesday, saying he will keep doing his job.
[...]
I'll go along with the FDA," said Fauci, the longtime director of the National Institute for Allergy and Infectious Diseases. "The overwhelming prevailing clinical trials that have looked at the efficacy of hydroxychloroquine have indicated that it is not effective in coronavirus disease."
[...]
Asked if he can continue to do his job when Trump continues to publicly question his credibility, Fauci said Tuesday he would press ahead "no matter what" because of the stakes involved.
"I don't tweet. I don't even read them, so I don't really want to go there," Fauci said.
[...]
" This is what I do. This is what I've been trained for my entire professional life, and I'll continue to do it."
Asked about claims he has been misleading the public, Fauci said: "I have not been misleading the American public under any circumstances."
[...]
Numerous studies, meanwhile, have shown that the drug, hydroxychloroquine, is not an effective treatment for COVID-19, the disease caused by the coronavirus. And the US Food and Drug Administration recently withdrew an order that allowed the drug's use as a emergency treatment for COVID-19.
[...]
Twitter Inc. on Tuesday said it had limited access to Donald Trump Jr's account for 12 hours, after he posted a video of doctors talking about hydroxychloroquine that violated the site's misinformation policy on COVID-19.
alJazeera
Tuesday, July 28, 2020
Still hawking hydroxychloroquine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment